Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -52.12%77.57M | -48.71%278.83M | -51.83%161.99M | -4.21%543.64M | -22.30%336.26M | 310.27%567.51M | 563.60%432.75M | 53.68%138.33M | 50.83%65.21M | -63.04%90.01M |
| Operating income | -52.12%77.57M | -48.71%278.83M | -51.83%161.99M | -4.21%543.64M | -22.30%336.26M | 310.27%567.51M | 563.60%432.75M | 53.68%138.33M | 50.83%65.21M | -63.04%90.01M |
| Cost of sales | 48.71%-67.82M | 53.43%-214.87M | 53.03%-132.24M | -2.17%-461.44M | 24.31%-281.52M | -364.86%-451.64M | -652.86%-371.94M | -22.18%-97.16M | -28.62%-49.4M | 61.34%-79.52M |
| Operating expenses | 48.71%-67.82M | 53.43%-214.87M | 53.03%-132.24M | -2.17%-461.44M | 24.31%-281.52M | -364.86%-451.64M | -652.86%-371.94M | -22.18%-97.16M | -28.62%-49.4M | 61.34%-79.52M |
| Gross profit | -67.24%9.75M | -22.19%63.96M | -45.64%29.75M | -29.06%82.2M | -9.99%54.73M | 181.45%115.87M | 284.65%60.81M | 292.58%41.17M | 227.58%15.81M | -72.30%10.49M |
| Selling expenses | 8.65%-10.83M | 40.08%-24.09M | 21.25%-11.85M | -64.37%-40.21M | -162.53%-15.05M | -983.87%-24.46M | ---5.73M | ---2.26M | ---- | ---- |
| Administrative expenses | 22.50%-59.83M | 39.70%-112.55M | -2.77%-77.2M | -25.94%-186.66M | -25.88%-75.12M | -23.16%-148.22M | -93.74%-59.67M | -111.14%-120.35M | -33.08%-30.8M | 31.73%-57M |
| Research and development expenses | 37.62%-33.64M | 26.61%-112.48M | 23.77%-53.92M | -123.12%-153.27M | -351.54%-70.73M | -1,671.38%-68.69M | ---15.67M | ---3.88M | ---- | ---- |
| Impairment and provision | 37.33%-2.67M | -5,694.75%-70.58M | -616.16%-4.25M | 84.18%-1.22M | -3.85%-594K | 83.42%-7.7M | ---572K | ---46.45M | ---- | ---- |
| -Goodwill impairment | ---- | ---67.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 37.33%-2.67M | -142.86%-2.96M | -616.16%-4.25M | 84.18%-1.22M | -3.85%-594K | 83.42%-7.7M | ---572K | ---46.45M | ---- | ---- |
| Special items of operating profit | 137.77%11.53M | -55.65%-36.22M | -73.87%-30.53M | 53.44%-23.27M | -180.88%-17.56M | 84.82%-49.98M | 15,604.29%21.71M | -5.78%-329.22M | -101.33%-140K | -26.05%-311.22M |
| Operating profit | 42.28%-91.91M | 9.68%-311.25M | -18.43%-159.23M | -59.24%-344.59M | -545.23%-134.45M | 54.81%-216.39M | 0.72%-20.84M | -31.33%-478.81M | -89.46%-20.99M | -19.24%-364.57M |
| Financing income | -25.42%7.38M | -8.07%18.49M | -1.60%9.9M | 133.67%20.11M | 123.04%10.06M | -23.88%8.61M | -17.60%4.51M | -21.37%11.31M | -25.90%5.47M | -36.84%14.38M |
| Financing cost | 52.56%-4.27M | 55.64%-11.04M | 58.04%-8.99M | -124.38%-24.88M | -31.64%-21.43M | -45.93%-11.09M | -302.10%-16.28M | 15.24%-7.6M | 33.48%-4.05M | 57.04%-8.97M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---257.81M | ---- |
| Earning before tax | 43.91%-88.8M | 13.04%-303.8M | -8.57%-158.33M | -59.62%-349.36M | -347.19%-145.83M | 53.93%-218.87M | 88.24%-32.61M | -32.28%-475.1M | -2,735.82%-277.37M | -18.20%-359.16M |
| Tax | 34.04%-4.48M | 27.53%-9.25M | -69.51%-6.79M | -23.75%-12.77M | 61.42%-4M | -30.99%-10.32M | -534.80%-10.38M | -3,742.93%-7.88M | 7.26%-1.64M | -102.88%-205K |
| After-tax profit from continuing operations | 43.51%-93.28M | 13.55%-313.05M | -10.20%-165.12M | -58.00%-362.13M | -248.54%-149.83M | 52.55%-229.19M | 84.59%-42.99M | -34.40%-482.98M | -2,316.90%-279.01M | -21.11%-359.36M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 173.91%56.92M | 242.26%56.92M | ---77.02M |
| Earning after tax | 43.51%-93.28M | 13.55%-313.05M | -10.20%-165.12M | -58.00%-362.13M | -248.54%-149.83M | 46.21%-229.19M | 80.64%-42.99M | 2.37%-426.05M | -330.75%-222.08M | -47.06%-436.38M |
| Minority profit | -26.32%-5.59M | 36.92%-9.24M | 45.86%-4.42M | -119.27%-14.65M | ---8.17M | 70.04%-6.68M | ---- | 55.12%-22.29M | 14.07%-22.29M | -149.18%-49.68M |
| Profit attributable to shareholders | 45.43%-87.69M | 12.57%-303.81M | -13.43%-160.7M | -56.16%-347.48M | -229.54%-141.67M | 44.89%-222.51M | 78.48%-42.99M | -4.41%-403.76M | -680.03%-199.79M | -39.71%-386.7M |
| Basic earnings per share | 45.16%-0.0119 | 12.37%-0.0411 | -15.43%-0.0217 | -60.07%-0.0469 | -229.82%-0.0188 | 49.74%-0.0293 | 80.34%-0.0057 | 0.34%-0.0583 | -643.59%-0.029 | -30.00%-0.0585 |
| Diluted earnings per share | 45.16%-0.0119 | 12.37%-0.0411 | -15.43%-0.0217 | -60.07%-0.0469 | -229.82%-0.0188 | 49.74%-0.0293 | 80.34%-0.0057 | 0.34%-0.0583 | -643.59%-0.029 | -30.00%-0.0585 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | PwC accounting firm | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.